Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Bryon Adinoff

Concepts (373)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
24
2020
133
6.360
 Why?
Alcoholism
22
2023
826
3.500
 Why?
Pituitary-Adrenal System
10
2020
164
2.420
 Why?
Opiate Substitution Treatment
4
2025
189
2.370
 Why?
Hypothalamo-Hypophyseal System
9
2020
199
2.320
 Why?
Brain
15
2025
2969
2.170
 Why?
Substance-Related Disorders
21
2018
1102
2.050
 Why?
Marijuana Use
4
2025
222
2.020
 Why?
Cerebrovascular Circulation
12
2016
290
1.730
 Why?
Opioid-Related Disorders
6
2025
605
1.630
 Why?
Behavior, Addictive
9
2018
88
1.610
 Why?
Methadone
2
2025
123
1.600
 Why?
Amphetamine-Related Disorders
5
2018
52
1.480
 Why?
Tomography, Emission-Computed, Single-Photon
13
2016
104
1.390
 Why?
Sunbathing
3
2018
16
1.340
 Why?
Limbic System
6
2012
55
1.250
 Why?
Health Services Accessibility
3
2025
1101
1.250
 Why?
Hydrocortisone
11
2023
298
1.240
 Why?
Neural Pathways
6
2019
317
1.160
 Why?
Prescription Drug Misuse
2
2019
53
1.050
 Why?
Central Nervous System Stimulants
8
2018
185
1.040
 Why?
Stress, Psychological
4
2020
1149
1.030
 Why?
Adrenocorticotropic Hormone
7
2020
147
1.020
 Why?
Temperance
6
2011
20
1.010
 Why?
Medical Marijuana
2
2019
122
0.990
 Why?
Hippocampus
4
2018
973
0.920
 Why?
Lidocaine
2
2020
55
0.900
 Why?
Procaine
5
2009
10
0.900
 Why?
Frontal Lobe
4
2012
160
0.890
 Why?
Adult
64
2025
40867
0.870
 Why?
Brain Mapping
10
2020
542
0.850
 Why?
Patient Acceptance of Health Care
3
2019
883
0.840
 Why?
Buprenorphine
2
2025
192
0.760
 Why?
Social Stigma
1
2025
173
0.750
 Why?
Humans
101
2025
145750
0.730
 Why?
Health Policy
1
2025
400
0.720
 Why?
Marijuana Smoking
1
2025
249
0.720
 Why?
Cerebral Cortex
8
2020
474
0.700
 Why?
Motivation
5
2019
601
0.680
 Why?
Middle Aged
46
2023
36297
0.660
 Why?
Nerve Net
3
2019
286
0.660
 Why?
Bupropion
2
2019
48
0.640
 Why?
Cues
3
2020
329
0.640
 Why?
Research Design
4
2022
1139
0.630
 Why?
Anesthetics, Local
3
2009
104
0.630
 Why?
Memory Consolidation
1
2020
14
0.620
 Why?
Naloxone
2
2016
132
0.620
 Why?
Drug-Seeking Behavior
1
2020
22
0.620
 Why?
Corticotropin-Releasing Hormone
4
2020
72
0.600
 Why?
Psychological Trauma
1
2020
57
0.590
 Why?
Crime
1
2019
57
0.590
 Why?
Male
63
2023
72992
0.590
 Why?
Antidepressive Agents, Second-Generation
2
2019
46
0.580
 Why?
Corpus Striatum
4
2018
179
0.580
 Why?
Legislation, Drug
1
2019
73
0.580
 Why?
Social Justice
1
2019
81
0.570
 Why?
Psychiatry
1
2022
195
0.570
 Why?
Impulsive Behavior
3
2014
145
0.550
 Why?
Naltrexone
2
2018
115
0.550
 Why?
Recurrence
9
2017
1139
0.540
 Why?
Adrenal Cortex
2
2010
33
0.530
 Why?
Alcohol Deterrents
1
2018
26
0.520
 Why?
Magnetic Resonance Imaging
13
2020
3915
0.520
 Why?
Outpatients
3
2017
447
0.520
 Why?
Alcohol Drinking
5
2023
843
0.520
 Why?
Pituitary Gland
2
2010
149
0.510
 Why?
Temporal Lobe
3
2017
107
0.500
 Why?
Stress Disorders, Post-Traumatic
4
2019
890
0.500
 Why?
Family Conflict
1
2017
42
0.500
 Why?
Drinking Behavior
1
2016
15
0.500
 Why?
Oxygen
4
2015
981
0.490
 Why?
Support Vector Machine
1
2016
33
0.490
 Why?
Methanol
1
2016
44
0.490
 Why?
Analgesics, Opioid
1
2025
1154
0.480
 Why?
Substance Abuse Treatment Centers
4
2014
49
0.480
 Why?
Self Concept
1
2018
254
0.470
 Why?
Optic Nerve Diseases
1
2016
49
0.470
 Why?
Young Adult
20
2025
14250
0.470
 Why?
Marijuana Abuse
1
2019
214
0.470
 Why?
Female
54
2020
79025
0.460
 Why?
Gyrus Cinguli
5
2020
97
0.460
 Why?
Liability, Legal
1
2016
42
0.450
 Why?
Ultraviolet Rays
2
2016
385
0.450
 Why?
Regional Blood Flow
4
2012
514
0.440
 Why?
Mortality
1
2018
380
0.440
 Why?
Self-Control
1
2016
53
0.440
 Why?
Case-Control Studies
10
2023
3634
0.440
 Why?
Dopamine
2
2016
295
0.430
 Why?
Neuroimaging
2
2016
300
0.430
 Why?
Narcotic Antagonists
4
2016
203
0.410
 Why?
Drug Overdose
2
2016
375
0.400
 Why?
Hyperventilation
1
2013
15
0.400
 Why?
Psilocybin
1
2013
5
0.400
 Why?
Human Experimentation
1
2013
12
0.390
 Why?
Glucocorticoids
2
2010
532
0.390
 Why?
Severity of Illness Index
4
2016
2933
0.390
 Why?
Personality
1
2014
129
0.370
 Why?
Bipolar Disorder
5
2017
291
0.370
 Why?
Confidentiality
1
2013
80
0.370
 Why?
Prefrontal Cortex
4
2020
336
0.370
 Why?
Methamphetamine
2
2013
74
0.360
 Why?
Ondansetron
1
2012
20
0.360
 Why?
Serotonin Antagonists
1
2012
32
0.360
 Why?
Cocaine
4
2020
162
0.360
 Why?
Psychomotor Performance
3
2019
324
0.350
 Why?
Algorithms
3
2016
1850
0.350
 Why?
Allostasis
2
2023
17
0.350
 Why?
Neuropeptide Y
1
2011
9
0.350
 Why?
Substance Withdrawal Syndrome
4
2010
185
0.340
 Why?
Hallucinogens
1
2013
111
0.340
 Why?
Patient Compliance
4
2013
588
0.330
 Why?
Intention
1
2012
186
0.330
 Why?
Radiopharmaceuticals
4
2016
205
0.320
 Why?
Decision Making
3
2016
981
0.320
 Why?
Emotions
1
2016
577
0.320
 Why?
Brain-Derived Neurotrophic Factor
1
2011
154
0.310
 Why?
Heart Rate
5
2016
856
0.310
 Why?
Predictive Value of Tests
1
2016
2123
0.310
 Why?
Receptors, Cholinergic
1
2010
41
0.310
 Why?
Double-Blind Method
9
2020
2064
0.310
 Why?
Anxiety
2
2020
1122
0.310
 Why?
Feedback, Physiological
1
2010
80
0.300
 Why?
Rest
2
2015
126
0.290
 Why?
Surveys and Questionnaires
7
2016
6084
0.290
 Why?
Community Health Services
1
2010
231
0.270
 Why?
Blood Pressure
6
2016
1782
0.270
 Why?
Cognition Disorders
1
2012
544
0.270
 Why?
Adrenal Insufficiency
1
2008
31
0.260
 Why?
Disruptive, Impulse Control, and Conduct Disorders
1
2007
9
0.250
 Why?
Acetylcholine
1
2007
209
0.250
 Why?
Occipital Lobe
1
2006
26
0.240
 Why?
United Kingdom
2
2025
358
0.240
 Why?
Functional Neuroimaging
3
2017
61
0.230
 Why?
Portugal
1
2025
10
0.230
 Why?
Russia
1
2025
12
0.230
 Why?
France
1
2025
40
0.230
 Why?
Iran
1
2025
44
0.230
 Why?
Cohort Studies
7
2019
6032
0.230
 Why?
Technetium Tc 99m Exametazime
3
2012
4
0.230
 Why?
United States
8
2025
16122
0.230
 Why?
Attention Deficit Disorder with Hyperactivity
3
2018
430
0.230
 Why?
Neural Inhibition
1
2007
178
0.230
 Why?
Cannabis
2
2025
510
0.220
 Why?
Neuropsychological Tests
3
2016
1137
0.220
 Why?
Australia
1
2025
291
0.210
 Why?
Randomized Controlled Trials as Topic
5
2015
1751
0.210
 Why?
Self Report
4
2018
875
0.210
 Why?
Treatment Outcome
12
2020
11793
0.210
 Why?
Canada
1
2025
432
0.210
 Why?
Attitude to Health
1
2007
430
0.200
 Why?
Personality Inventory
2
2014
134
0.190
 Why?
Smoking Cessation
4
2015
441
0.180
 Why?
Alcoholic Intoxication
1
2003
76
0.180
 Why?
Neostriatum
2
2016
37
0.180
 Why?
Global Health
1
2025
403
0.180
 Why?
Saliva
1
2003
249
0.170
 Why?
Health Behavior
1
2007
789
0.170
 Why?
Affect
3
2016
321
0.170
 Why?
Executive Function
3
2016
470
0.170
 Why?
Kindling, Neurologic
1
2001
2
0.170
 Why?
Smoking
3
2013
1477
0.170
 Why?
Alcohol Withdrawal Delirium
2
2003
9
0.170
 Why?
Models, Neurological
2
2018
250
0.160
 Why?
Magnetic Resonance Angiography
2
2014
251
0.160
 Why?
gamma-Aminobutyric Acid
2
2008
194
0.160
 Why?
Pituitary-Adrenal Function Tests
1
2020
3
0.160
 Why?
Voltage-Gated Sodium Channel Blockers
1
2020
7
0.160
 Why?
Antimanic Agents
2
2017
19
0.160
 Why?
Dexamethasone
2
2005
365
0.160
 Why?
Prazosin
1
2020
25
0.160
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2020
18
0.160
 Why?
Family Health
2
2013
191
0.150
 Why?
Reward
2
2016
248
0.150
 Why?
Anticipation, Psychological
1
2020
20
0.150
 Why?
Amygdala
2
2016
200
0.150
 Why?
Sex Factors
5
2014
2110
0.150
 Why?
Age Factors
2
2025
3346
0.150
 Why?
Psychological Tests
1
2020
130
0.150
 Why?
Psychiatric Status Rating Scales
5
2014
533
0.150
 Why?
Public Policy
1
2019
80
0.150
 Why?
Reproducibility of Results
3
2016
3416
0.140
 Why?
Endophenotypes
1
2018
23
0.140
 Why?
Product Surveillance, Postmarketing
1
2019
74
0.140
 Why?
Harm Reduction
1
2019
49
0.140
 Why?
Emergency Service, Hospital
3
2019
2383
0.140
 Why?
Drug Evaluation, Preclinical
1
2019
196
0.140
 Why?
Narcolepsy
1
2018
25
0.130
 Why?
Alcohol-Related Disorders
2
2013
121
0.130
 Why?
Ethanol
2
2003
631
0.130
 Why?
Adolescent
11
2025
22569
0.130
 Why?
Risk Factors
4
2018
10916
0.130
 Why?
Drug Therapy, Combination
2
2018
1044
0.130
 Why?
Sensitivity and Specificity
3
2016
2000
0.120
 Why?
Choice Behavior
1
2018
180
0.120
 Why?
Dehydroepiandrosterone
1
1996
49
0.120
 Why?
Exercise Test
2
2016
630
0.120
 Why?
Ultraviolet Therapy
1
2016
17
0.120
 Why?
Methylphenidate
2
2015
49
0.120
 Why?
Skin Neoplasms
2
2016
852
0.120
 Why?
Autonomic Nervous System
1
2016
83
0.120
 Why?
Antipsychotic Agents
2
2017
211
0.120
 Why?
Follow-Up Studies
4
2017
5428
0.120
 Why?
Data Interpretation, Statistical
2
2015
368
0.120
 Why?
Animals
6
2020
38100
0.120
 Why?
Erythropoietin
1
2016
100
0.110
 Why?
Image Processing, Computer-Assisted
3
2012
782
0.110
 Why?
Cytidine Diphosphate Choline
1
2015
2
0.110
 Why?
Research
1
2019
431
0.110
 Why?
Receptors, Dopamine D2
1
2016
93
0.110
 Why?
Nootropic Agents
1
2015
30
0.110
 Why?
Cluster Analysis
1
2016
501
0.110
 Why?
Psoriasis
1
2016
115
0.110
 Why?
Population Surveillance
1
2018
484
0.110
 Why?
Computer Graphics
1
2015
41
0.110
 Why?
Parietal Lobe
1
2015
61
0.110
 Why?
Stress, Physiological
1
1998
443
0.110
 Why?
Dibenzothiazepines
1
2014
18
0.110
 Why?
Proportional Hazards Models
1
2018
1330
0.100
 Why?
Residential Treatment
1
2014
30
0.100
 Why?
Anti-Inflammatory Agents
1
1997
478
0.100
 Why?
Functional Laterality
1
2015
240
0.100
 Why?
Menthol
1
2013
11
0.100
 Why?
Cognition
2
2016
1271
0.100
 Why?
Heroin Dependence
1
2014
33
0.100
 Why?
Clinical Trials as Topic
1
2019
1062
0.100
 Why?
Time Factors
3
2016
7133
0.100
 Why?
Drug Users
1
2013
43
0.100
 Why?
Texas
2
2012
273
0.100
 Why?
United States Department of Veterans Affairs
1
2018
779
0.100
 Why?
Self Care
1
2016
392
0.100
 Why?
September 11 Terrorist Attacks
1
2013
31
0.100
 Why?
Prehypertension
1
2012
27
0.090
 Why?
Image Interpretation, Computer-Assisted
1
2015
288
0.090
 Why?
Mexican Americans
1
2014
119
0.090
 Why?
Buspirone
1
2012
5
0.090
 Why?
Tobacco Products
1
2013
84
0.090
 Why?
Serotonin Receptor Agonists
1
2012
27
0.090
 Why?
Parahippocampal Gyrus
1
2012
11
0.090
 Why?
Carrier Proteins
1
1996
729
0.090
 Why?
Retrospective Studies
3
2018
17322
0.090
 Why?
Receptors, Serotonin, 5-HT3
1
2012
16
0.090
 Why?
Recovery of Function
1
2016
716
0.090
 Why?
Spin Labels
1
2011
59
0.090
 Why?
Conditioning, Classical
1
2012
119
0.090
 Why?
Reference Values
2
2003
798
0.090
 Why?
Photic Stimulation
1
2012
264
0.090
 Why?
Sodium Chloride
1
2012
138
0.080
 Why?
Subthalamic Nucleus
1
2012
84
0.080
 Why?
Life Change Events
2
2013
147
0.080
 Why?
Speech
1
2011
76
0.080
 Why?
Analysis of Variance
2
2003
1300
0.080
 Why?
Secondary Prevention
1
2012
251
0.080
 Why?
Health Status
1
2016
835
0.080
 Why?
Anti-Anxiety Agents
1
2010
48
0.080
 Why?
Physostigmine
1
2010
13
0.080
 Why?
Age of Onset
1
2012
557
0.080
 Why?
Cholinergic Antagonists
1
2010
24
0.080
 Why?
Cholinesterase Inhibitors
1
2010
47
0.080
 Why?
Depressive Disorder
1
2012
374
0.080
 Why?
Propensity Score
3
2016
377
0.070
 Why?
Tobacco Use Disorder
1
2011
217
0.070
 Why?
Conduct Disorder
1
2011
158
0.070
 Why?
Survivors
1
2013
523
0.070
 Why?
Factor Analysis, Statistical
1
2010
291
0.070
 Why?
Exercise
3
2016
2203
0.070
 Why?
Statistics, Nonparametric
1
2010
428
0.070
 Why?
Dopamine Plasma Membrane Transport Proteins
1
2009
59
0.070
 Why?
Memory
2
2010
297
0.070
 Why?
Nicotine
1
2011
331
0.070
 Why?
Adrenal Cortex Function Tests
1
2008
1
0.070
 Why?
Receptors, Cannabinoid
1
2008
13
0.070
 Why?
Depression
1
2018
1557
0.070
 Why?
Chronic Disease
1
2014
1810
0.070
 Why?
Parasympathetic Nervous System
1
2007
26
0.070
 Why?
Automatism
1
2007
1
0.060
 Why?
Cross-Sectional Studies
5
2016
5921
0.060
 Why?
Quetiapine Fumarate
2
2017
26
0.060
 Why?
Adaptation, Psychological
2
2011
719
0.060
 Why?
Mass Screening
2
2012
1361
0.060
 Why?
Prognosis
1
2015
4329
0.060
 Why?
Psychometrics
1
2010
731
0.060
 Why?
Receptors, N-Methyl-D-Aspartate
1
2008
229
0.060
 Why?
Serotonin
1
2008
298
0.060
 Why?
Cortodoxone
1
2005
1
0.060
 Why?
Endorphins
1
2005
9
0.060
 Why?
Diagnosis, Dual (Psychiatry)
3
2014
39
0.060
 Why?
Cosyntropin
1
2005
7
0.060
 Why?
Blood Flow Velocity
1
2006
421
0.050
 Why?
Prevalence
2
2013
2874
0.050
 Why?
Aged
4
2018
26212
0.050
 Why?
Demography
1
2005
282
0.050
 Why?
Comorbidity
4
2017
1662
0.050
 Why?
Obesity
1
2018
3118
0.050
 Why?
Mathematical Computing
1
2003
11
0.050
 Why?
Gambling
1
2003
29
0.050
 Why?
Linear Models
2
2016
849
0.050
 Why?
Breath Tests
1
2003
77
0.050
 Why?
Nucleus Accumbens
1
2004
135
0.050
 Why?
Learning
1
2007
444
0.050
 Why?
Dominance, Cerebral
1
2003
56
0.050
 Why?
Single-Blind Method
1
2003
318
0.050
 Why?
Sheep
1
2005
876
0.050
 Why?
Infusions, Intravenous
1
2003
428
0.040
 Why?
Adrenal Cortex Hormones
1
2005
484
0.040
 Why?
Patient Admission
1
2003
220
0.040
 Why?
Mental Disorders
1
2010
1169
0.040
 Why?
Residence Characteristics
2
2015
375
0.040
 Why?
National Institute on Drug Abuse (U.S.)
2
2011
3
0.040
 Why?
C-Reactive Protein
1
2023
423
0.040
 Why?
Placebos
1
2001
193
0.040
 Why?
Uncertainty
1
2020
146
0.040
 Why?
Genetic Predisposition to Disease
1
2008
2399
0.040
 Why?
Dose-Response Relationship, Drug
1
2002
2028
0.030
 Why?
Child
2
2016
22738
0.030
 Why?
Organ Size
1
2018
461
0.030
 Why?
Valproic Acid
1
2017
49
0.030
 Why?
Diazepam Binding Inhibitor
1
1996
2
0.030
 Why?
Disease Models, Animal
1
2007
4569
0.030
 Why?
Heliotherapy
1
2016
1
0.030
 Why?
Tanning
1
2016
1
0.030
 Why?
Liver Function Tests
1
1995
105
0.030
 Why?
Neurologic Examination
1
1995
132
0.030
 Why?
Nutrition Surveys
1
2016
279
0.030
 Why?
Blood-Brain Barrier
1
1995
160
0.030
 Why?
Craving
1
2014
40
0.030
 Why?
Signal Processing, Computer-Assisted
1
2015
152
0.030
 Why?
Basal Metabolism
1
2014
59
0.030
 Why?
Automation
1
2014
104
0.030
 Why?
Delayed-Action Preparations
1
2014
189
0.020
 Why?
New York City
1
2013
84
0.020
 Why?
Aged, 80 and over
2
2018
8346
0.020
 Why?
Self Administration
1
2013
122
0.020
 Why?
Mexico
1
2014
233
0.020
 Why?
Stroop Test
1
2013
24
0.020
 Why?
Blood Circulation Time
1
2011
3
0.020
 Why?
Disasters
1
2013
100
0.020
 Why?
Motivational Interviewing
1
2013
121
0.020
 Why?
Psychotherapy, Brief
1
2011
41
0.020
 Why?
Models, Statistical
1
2015
672
0.020
 Why?
Clinical Protocols
1
2012
280
0.020
 Why?
Informed Consent
1
2012
199
0.020
 Why?
Combat Disorders
1
2010
42
0.020
 Why?
Multicenter Studies as Topic
1
2012
413
0.020
 Why?
Aftercare
1
2012
222
0.020
 Why?
Nicotinic Agonists
1
2011
135
0.020
 Why?
Rats
1
2018
5585
0.020
 Why?
Risk-Taking
1
2012
323
0.020
 Why?
Family
1
2014
684
0.020
 Why?
Contrast Media
1
2011
497
0.020
 Why?
Body Weight
1
2012
972
0.020
 Why?
Longitudinal Studies
1
2016
2967
0.020
 Why?
Nerve Fibers, Myelinated
1
2008
47
0.020
 Why?
Socioeconomic Factors
1
2012
1327
0.020
 Why?
Medication Adherence
1
2012
540
0.020
 Why?
Pregnancy Complications
1
2013
603
0.020
 Why?
Logistic Models
1
2012
2139
0.020
 Why?
Biomarkers
1
2018
4302
0.020
 Why?
Regression Analysis
1
2009
1001
0.020
 Why?
Hypothalamus
1
2008
163
0.020
 Why?
Risk Assessment
1
2016
3752
0.010
 Why?
Incidence
1
2013
2933
0.010
 Why?
Referral and Consultation
1
2012
868
0.010
 Why?
Survival Analysis
1
2009
1378
0.010
 Why?
Peer Group
1
2008
255
0.010
 Why?
Synapses
1
2008
439
0.010
 Why?
Pilot Projects
1
2009
1897
0.010
 Why?
Military Personnel
1
2010
737
0.010
 Why?
Pregnancy
1
2013
7215
0.010
 Why?
Diagnostic Errors
1
2001
178
0.010
 Why?
Quality of Life
1
2012
3210
0.010
 Why?
Prospective Studies
1
2011
8075
0.010
 Why?
Carbamazepine
1
1995
24
0.010
 Why?
Psychoses, Substance-Induced
1
1995
16
0.010
 Why?
Adinoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (2) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)